Physician profile
Salil Kumar
NPI 1306292495
$2,896.16
in general payments reported to CMS, 2019-2025
14 companies · $35.81 in 2025
The $35.81 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $37.99 · 2022: $53.77 · 2023: $2,424 · 2024: $344 · 2025: $35.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,565 · Education: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,564.90 |
| Education | $239.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,080.29 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Gallant |
| Amgen INC. | $147.33 | 2023 | Repatha |
| Abiomed | $144.49 | 2023 | Impella |
| Impulse Dynamics (USA) INC. | $139.62 | 2024 | Optimizer |
| Pfizer INC. | $91.76 | 2021-2022 | |
| Medtronic, INC. | $90.07 | 2023-2024 | Cobalt Dr Mri Surescan, Mycarelink, Capsurefix Novus Mri Surescan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.66 | 2023 | Jardiance |
| Lantheus Medical Imaging, INC. | $35.67 | 2023 | Definity |
| Csl Behring | $26.81 | 2023 | Kcentra |
| Alnylam Pharmaceuticals INC. | $26.57 | 2023 | Onpattro |
| Edwards Lifesciences Corporation | $25.26 | 2023 | The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System |
| Kiniksa Pharmaceuticals, Ltd. | $16.79 | 2023 | Arcalyst |
| Astrazeneca Pharmaceuticals Lp | $12.84 | 2023 | Farxiga |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salil Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.